Sonosite and Medical Simulation Corporation to Demonstrate Safe Central Line Placement Techniques at AACN Meeting
BOTHELL, WA - May 15, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, today announced that Medical Simulation Corporation (MSC) has selected Sonosite's M-Turbo® ultrasound as their preferred system for teaching clinicians central line placement procedures for their SimSuite® Central Line Management Program. MSC is the leader in providing full-service simulation training and education services to healthcare personnel, medical societies and medical product manufacturers. "Medical Simulation Corporation is proud to partner with Sonosite as its preferred ultrasound vendor for the SimSuite Central Line Management Program," Bill Younkes, MSC President and CEO said.
"Throughout the selection process, Sonosite's M-Turbo ultrasound system rose to the top in head-to-head demonstrations with multiple vendors and met our needs for portability and exceptional image quality. Along with their 5-year warranty; Sonosite's work with the military speaks volumes about their system's reliability."… [Read more]
Conference Call Today at 1:30 PM Pacific Time
BOTHELL, WA - April 27, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, today announced financial results for the first quarter ended March 31, 2009. First quarter 2009 worldwide revenue was $51.8 million, a decrease of 1% over the prior year's first quarter as previously announced. Changes in foreign currency rates decreased worldwide revenue in the first quarter of 2009 by approximately 8%. Total US revenue grew 5% in the quarter to $23.2 million driven by more than doubling of revenue in the enterprise channel. US direct hospital sales were negatively impacted by the slowdown in hospital capital spending - down 14%. International sales were down 6% to $28.6 million due to a 14% negative foreign exchange impact. On a constant currency basis, international sales were up 8%.… [Read more]
BOTHELL, WA - April 20, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, said today that it will report the company's first quarter financial results on Monday, April 27, 2009 at the close of market and host a conference call at 1:30 pm PT/4:30 ET. The company announced preliminary first quarter revenue results on April 7, 2009. The call will be broadcast live and can be accessed via the "investors" Section on Sonosite's website at (www.sonosite.com). A replay of the audio webcast will be available beginning April 27, 2009, 5:30 pm PT and will be available until May 11, 2009, 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 8899954 is required to access the replay. The call will also be archived on Sonosite's website.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 650 people worldwide.… [Read more]
Sonosite Previews Preliminary First Quarter Revenue Results
BOTHELL, WA - April 6, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, today provided preliminary revenue results for the first quarter ended March 31, 2009. The company said worldwide revenue decreased by 1% - 2% in Q1 2009 compared to Q1 2008. On a constant currency basis, worldwide revenues grew 6% - 7% in the quarter, indicating a currency headwind of approximately 8%. US revenues grew approximately 4% year over year.
Continued slowing of US hospital capital spending drove a mid-teen percentage decline in Sonosite€™s US hospital revenues. This was offset by excellent growth in the company€™s US enterprise channel. International revenues decreased approximately 6% in the quarter, driven by the impact of a weaker dollar. On a constant currency basis the International sector was up approximately 8% in Q1 2009 on a year over year basis. These revenue estimates are preliminary. The company will report full financial results for the first quarter on April 27, 2009 after the close of market.
About Sonosite… [Read more]
Sonosite Participating in HIMSS Interoperability Showcase
BOTHELL, WA - April 2, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, will demonstrate its latest advances in connectivity and workflow integration technology on the Sonosite Turbo™ platform, during the Healthcare Information and Management System Society (HIMSS) 2009 Conference. The conference is being held in Chicago at McCormick Place, April 4-8th.
As a participant at the HIMSS' Interoperability Showcase, Sonosite will conduct live demonstrations on its M-Turbo® system to show how it communicates with multiple DICOM® compliant products to expedite workflow. Both the M-Turbo and S Series™ product lines support the following DICOM functions: Storage Commitment, Modality Performed Procedure Step (MPPS), Modality Work List (MWL), Print and Archive.… [Read more]
New User Interface, Larger Screen Size and Exceptional Image Quality
BOTHELL, WA - December 21, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced it has received CE Marking (Conformité Européenne) in the European Union to market its next generation point-of-care product: EDGE™ ultrasound system. The EDGE system is currently available for sale in the U.S., following receipt of FDA Premarket Notification 510(k) clearance in November. Sonosite is now commencing international customer deliveries.
Engineered with new state-of-the-art technology, the EDGE ultrasound system takes point-of- care ultrasound to a whole new level of clinical performance and enables physicians to deliver the highest standard of patient care by driving greater efficiencies and the potential for improved outcomes in the hospital and office.
The EDGE ultrasound was formally introduced this fall at medical meetings and congresses in Europe and Australia. Physicians positively responded to the system:… [Read more]
Company Received FDA 510(k) Clearance and is Now Shipping the EDGE System to US Customers
BOTHELL, WA - November 17, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has received FDA 510(k) clearance for its fifth generation, high performance EDGE™ ultrasound system. Designed with physician feedback in mind, the EDGE system reaches a new level of clinical performance and product design, arming physicians with a tool to deliver better, safer and improved patient care. The company is now commencing US customer deliveries. International deliveries are pending CE marking.
“The EDGE system is a tremendous product and we are excited to bring it to point-of-care medicine, said Kevin M. Goodwin, Sonosite’s President and CEO. “We are encouraged by the timely regulatory review process, which represents a collaborative effort by many. We look forward to adding this new tool to our core markets and providing physicians with the impact they have been asking for in healthcare delivery.”… [Read more]
BOTHELL, WA– November 16, 2011– Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Richard Salzar as the Vice President and General Manager of Europe, Russia, and Africa.
“Richard is a strong leader with 30 years of experience in the healthcare industry,” said Kevin M. Goodwin, Sonosite’s President and CEO. “As we continue to position ourselves for growth in our international markets, Richard’s past success at the strategic and business level will further strengthen our ability to expand our international footprint. We anticipate optimally structuring our approach for improved execution and growth heading into 2012.”
“Sonosite is a unique company with a superior product line and long-term market opportunity,” said Richard Salzar. “I’m excited for the opportunity to join the company and I’m confident in my ability to leverage our current resources internationally and drive strong results in the coming years.”
… [Read more]
BOTHELL, WA– November 15, 2011– Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced the appointment of Brian Noyes as the Vice President of Marketing for North America and South America.
“Brian is an excellent addition to Sonosite and we welcome him to the leadership team,” said Matthew Damron, Sonosite’s Global Chief Marketing Officer. “He is an accomplished leader with decades of experience in the medical device industry, a successful product launch track record, and a key factor in the growth of a $1 billion franchise at Johnson & Johnson. Brian is a very appealing candidate to further elevate our marketing execution to the next level with expertise that is essential as we prepare to unleash the most exciting products in our company’s history.”
“Sonosite is a company with tremendous growth opportunities and has an enviable position in the healthcare industry,” said Brian Noyes. “I’m joining the company at a very exciting time, and I look forward to capitalizing on the current marketing initiatives, driving product demand, and market expansion.”
… [Read more]
Revenues Hit $75.7 Million in the Quarter, Up 10%
Year-to-Date Revenues Reach $219.5 Million, Up 18%
Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern
BOTHELL, WA - October 25, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2011.
REVENUE
Revenues for the third quarter of 2011 were $75.7 million, rising 10% in comparison to $68.5 million in the third quarter of 2010.
Revenues for the nine months of 2011 were $219.5 million, compared to $186.1 million in 2010, an increase of 18%.
Overall order booking rates increased 16% in the quarter.
Foreign exchange contributed to a 2.1% favorable impact on third quarter results and a 2.8% favorable impact on the first nine months of 2011.
EBITDAS, EBITDA and OPERATING INCOME (EBIT)
Third Quarter:
For the quarter, EBITDAS includes non-recurring severance charges of $1.3 million from SG&A cost restructuring. Operating expense run rate savings are projected at $6.0 million for 2012, positioning the company for improved operating margins while launching new products and driving marketing initiatives in 2012.… [Read more]
Sponsored by Mt. Sinai Hospital, The Louis J. Acompora Memorial Foundation, and The Dominic A. Murray 21 Memorial Foundation
Free Screening October 22nd at Northport High School, Northport, New York
BOTHELL, WA - October 20, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for point-of-care medicine, proudly supports a community heart health screening to raise awareness and prevent sudden cardiac arrest in young adults.
Sponsored by the Louis J. Acompora Memorial Foundation, the Dominic A. Murray 21 Memorial Foundation and The Mount Sinai Hospital, the company will be providing physicians with its flagship M-Turbo ultrasound systems to perform a non-invasive cardiac ultrasound examination for the accurate evaluation of heart functionality, valve complications, and blood flow. Students between the ages of 14-24 are eligible for a free heart screening. The event will take place on October 22nd at the Northport High School in New York.… [Read more]
Anil Amlani Appointed as New Chief Financial Officer
Effective January 5th
BOTHELL, WA– December 27, 2011– Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that Marcus Smith will resign as Senior Vice President, Chief Financial Officer and Treasurer, effective as of January 2, 2012 and will be leaving the company effective as of January 5, 2012. Anil Amlani, the current President and Chief Executive Officer of Sonosite’s VisualSonics subsidiary, has been appointed the new Chief Financial Officer of Sonosite, effective as of January 2, 2012.
“Anil is a seasoned executive and operator, and is an ideal successor to serve as Sonosite’s new CFO,” said Kevin M. Goodwin, Sonosite’s President and CEO. “For the past 20 years, he has successfully led businesses. He also has served as a Chief Financial Officer for public and non-public companies for 11 years in total. More recently, Anil has led our VisualSonics business before and after the acquisition in June 2010. His broad experience base and global perspective will position Sonosite well.”… [Read more]
Subcommittee on Primary Health and Aging to Explore Stemming More Than 1000 Preventable Deaths Each Day In The US Healthcare System
BOTHELL, WA, July 17, 2014 – FUJIFILM Sonosite Inc., the world leader and specialist in ultrasound performed at the point-of-care, applauds the US Senate Subcommittee on Primary Health and Aging for having a hearing to explore ways to stem the more than 1000 preventable patient deaths a day in the US healthcare system.
"This crisis needs to be addressed at the highest levels sooner rather than later, and we applaud the Senate for taking action," said Diku Mandavia, MD, Senior Vice President and Chief Medical Officer at FUJIFILM Sonosite. "The fact is that there are many tools and methods to prevent these deaths if adopted broadly across a hospital, including those to significantly reduce a major threat to patient safety –hospital-acquired conditions."
Hospital-acquired conditions (HACs) are complications that a patient may develop during a stay in a hospital or medical facility. To reduce this patient risk, many leading hospitals now mandate that their physicians adopt proven best practises. As an example, the Agency for Healthcare Research and Quality (AHRQ), as well as other medical groups recommend ultrasound-guided central line insertion for safer vascular access, based on overwhelming scientific evidence of its safety benefits.… [Read more]
BOTHELL, WA - October 27, 2008 - Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in hand-carried ultrasound for point of care medicine, announced today the introduction of SonoGT™ Global Targeted technology, an advance that caliptalises on the power of the M-Turbo platform to drive a new level of colour flow imaging, wireless connectivity and workflow integration for anaesthesia, emergency medicine, critical care and other acute point-of-care markets. "SonoGT technology demonstrates the intrinsic capabilities of the M-Turbo system architecture to address our global, multiple point-of-care markets with targeted solutions," said Kevin M. Goodwin, Sonosite President and CEO. "This advance is aimed at increasing imaging capabilities and clinical productivity and includes a wide range of new technologies and options." The company plans to begin customer shipments of new M-Turbo systems with SonoGT technology in the fourth quarter. Customers can separately purchase SonoGT technology and upgrade existing M-Turbo systems via an easy software download from a USB thumb drive. The new SonoGT technology platform offers the following capabilities: Colour Performance
ColourHD™ Technology - A proprietary, colour Doppler algorithm that harnesses the power of the M-Turbo system's digital signal processor to increase colour performance, sensitivity and frame rates.
… [Read more]
BOTHELL, WA - July 30, 2007 - Sonosite, Inc., (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today it has acquired LumenVu, Inc., a privately held, development stage company based in Philadelphia. LumenVu, in conjunction with a leading academic research institution, has developed a patented technology to improve the accuracy of catheter placement. The acquisition will strengthen Sonosite's position in the vascular access market as well as add a recurring revenue stream via the disposable catheter guidance device. Sonosite expects to introduce products based on this technology in late 2008. Terms of the agreement were not disclosed and the transaction is not expected to have a material effect on Sonosite's 2007 financial results."The combination of Sonosite's hand-carried ultrasound technology with LumenVu's innovative catheter tracking technology will offer clinicians a major benefit in accurately and cost-effectively placing catheters at the bedside," said Thomas J. Dugan, Senior Vice President, Global Marketing and US Sales. "Clinicians have been rapidly adopting Sonosite's hand-carried ultrasound systems to increase the accuracy and speed of catheter insertion. LumenVu's technology will offer the perfect complement to ultrasound by providing a way to easily track the tip of the catheter as it advances through the vessel to ensure that it is placed in the right location, potentially eliminating the need to confirm the location with x-ray or fluoroscopy."… [Read more]
BOTHELL, WA - August 20, 2007 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand carried ultrasound, announced today it has appointed Marcus Y. Smith as Vice President, Corporate Development. In that position, Mr. Smith will be a member of Sonosite's Executive Committee and report to Kevin M. Goodwin, Sonosite President and CEO. Mr. Smith joins Sonosite from Philips Medical Systems (PMS) where he served as Senior Director, Strategy and Business Development since 2004. In this capacity he was responsible for directing strategy and business development efforts for Patient Monitoring and Cardiac Care, a $1 billion medical technology division of PMS. While at Philips, Mr. Smith built and executed on a strong portfolio of growth opportunities focused on strengthening core business and expansion into new critical care markets. From 2000 to 2003, Mr. Smith led JPMorgan's European logistics investment banking practice as Vice President, Investment Banking for the firm and advised major corporate and government clients on strategic alternatives in the logistics and transportation sectors. He originated and executed a broad range of transactions, including mergers, acquisitions, joint ventures, strategic alliances, equity, debt and derivatives.… [Read more]
BOTHELL, WA - July 16, 2007 - Sonosite, Inc., (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced the closing of its offering of $200 million aggregate principal amount of Convertible Senior Notes due 2014 in an offering registered under the Securities Act of 1933 as amended (the "Securities Act"). The notes will pay interest semiannually at a rate of 3.75% per annum. In certain circumstances, the notes will be convertible based on an initial conversion rate of 26.1792 shares of common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $38.20 per share. Conversions will be settled in cash up to the principal amount of the notes, with any conversion value above the principal amount settled in shares of Sonosite's common stock. Holders of the notes may require Sonosite to repurchase the notes for cash equal to 100% of the principal amount to be repurchased plus accrued and unpaid interest upon the occurrence of a fundamental change. Sonosite has granted the underwriters a 30-day option to purchase up to $25 million in aggregate principal amount of additional notes to cover over-allotments.… [Read more]
Judge Reverses Earlier Infringement RulingGrants Sonosite Motion For Summary Judgment
BOTHELL, WA - March 22, 2006 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today that the United States District Court for the Southern District of Texas, Houston Division, has granted Sonosite's motion for summary judgment of invalidity against Neutrino Development Corporation (Neutrino), a patent holding company. Based on the holding of invalidity, the court reversed its earlier finding that Sonosite infringed Neutrino's patent, US Patent No. 6,221,021 ("the '021 patent").
"This is a major victory for Sonosite and we are very pleased that the judge agreed with us that our products do not infringe Neutrino's patent," said Kevin M. Goodwin, Sonosite President and CEO. "Our technology and products are based on years of innovation and dedication by our employees. We look forward to having the distraction of this unfounded lawsuit behind us and continuing to develop products that are changing medical practice by bringing the benefits of ultrasound visualization to the point of patient care."
In the ruling issued yesterday, March 21, 2006, the court found that Neutrino improperly amended the '021 patent in violation of US patent law to include a claim of a component being handheld which was not in the original patent application.… [Read more]
Leading Health Care Group Purchasing Organization Adds State-of-Art Hand-Carried Ultrasound Systems to its National Contract PortfolioBOTHELL, WA - August 30, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, today announced it has signed a three-year, dual-source supply agreement with Novation for portable and vascular access ultrasound equipment and accessories. Novation is the supply company of VHA Inc. and the University Health System Consortium (UHC), two national health care alliances that serve approximately 2,500 health care providers nationwide. "We awarded this agreement to Sonosite based on member surveys, the recommendation of our member-based Diagnostic Imaging Capital Equipment task force and a public competitive bid process," said Cynthia Longueville, Novation senior product manager. "Novation looks forward to working with Sonosite to provide VHA and UHC members products that offer the best combination of quality, service and value."… [Read more]
BOTHELL, WA - August 10, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, announced today the appointment of Graham D. Cox as Vice President of its international business. Henry (Skip) A. Krause, who has led Sonosite's international division for the past two years, is resigning his position for personal family reasons, effective September 12, 2005."Skip has made significant contributions to expanding our presence into new international markets and successfully re-engineered our distribution in Japan," said Kevin M. Goodwin, Sonosite President and CEO. "We appreciate his efforts and wish Skip and his family all the best in the future.""We are fortunate to have an executive of Graham Cox's caliber and ultrasound experience who is well qualified to immediately assume leadership of our international business," Goodwin said. "Graham's proven leadership in establishing and growing our operations in Europe, Africa and the Middle East, provides an excellent base from which to lead and maintain our strong momentum in international markets."… [Read more]